227 related articles for article (PubMed ID: 32553611)
21. Immunology of systemic sclerosis.
Artlett CM
Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
[TBL] [Abstract][Full Text] [Related]
22. Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors.
Maria ATJ; Partouche L; Goulabchand R; Rivière S; Rozier P; Bourgier C; Le Quellec A; Morel J; Noël D; Guilpain P
Front Immunol; 2018; 9():3112. PubMed ID: 30687318
[TBL] [Abstract][Full Text] [Related]
23. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
[TBL] [Abstract][Full Text] [Related]
24. Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.
Kumar S; Singh J; Rattan S; DiMarino AJ; Cohen S; Jimenez SA
Aliment Pharmacol Ther; 2017 Apr; 45(7):883-898. PubMed ID: 28185291
[TBL] [Abstract][Full Text] [Related]
25. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
[TBL] [Abstract][Full Text] [Related]
26. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic roles of B lymphocytes in systemic sclerosis.
Yoshizaki A
Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
[TBL] [Abstract][Full Text] [Related]
28. Systemic sclerosis. A clinical overview.
Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers of skin and lung fibrosis in systemic sclerosis.
Martinović Kaliterna D; Petrić M
Expert Rev Clin Immunol; 2019 Nov; 15(11):1215-1223. PubMed ID: 31539483
[No Abstract] [Full Text] [Related]
30. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations.
Savas N; Dagli U; Ertugrul E; Kuran S; Sahin B
Dig Dis Sci; 2007 Nov; 52(11):3081-6. PubMed ID: 17393310
[TBL] [Abstract][Full Text] [Related]
31. The contemporary management of systemic sclerosis.
Eldoma M; Pope J
Expert Rev Clin Immunol; 2018 Jul; 14(7):573-582. PubMed ID: 29874475
[TBL] [Abstract][Full Text] [Related]
32. Functional autoantibodies in systemic sclerosis pathogenesis.
Kill A; Riemekasten G
Curr Rheumatol Rep; 2015 May; 17(5):34. PubMed ID: 25876754
[TBL] [Abstract][Full Text] [Related]
33. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
Radić M; Kaliterna DM; Fabijanić D; Radić J
Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
[TBL] [Abstract][Full Text] [Related]
34. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
35. Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
Pignone A; Scaletti C; Matucci-Cerinic M; Vázquez-Abad D; Meroni PL; Del Papa N; Falcini F; Generini S; Rothfield N; Cagnoni M
Clin Exp Rheumatol; 1998; 16(5):527-32. PubMed ID: 9779298
[TBL] [Abstract][Full Text] [Related]
36. Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians.
Keret S; Rimar D; Lansiaux P; Feldman E; Lescoat A; Milman N; Farge D;
Autoimmun Rev; 2023 Jun; 22(6):103314. PubMed ID: 36918090
[TBL] [Abstract][Full Text] [Related]
37. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
38. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
[TBL] [Abstract][Full Text] [Related]
39. [Renal involvement in systemic sclerosis].
Guerini S; Cavazzana I; Venturelli C; Rozzi M; Turina S; Sottini L; Tardanico R; Franceschini F; Scolari F
G Ital Nefrol; 2007; 24(4):295-310. PubMed ID: 17659501
[TBL] [Abstract][Full Text] [Related]
40. [Plasmapheresis therapy in systemic sclerosis].
Szúcs G; Szamosi S; Aleksza M; Veres K; Soltész P
Orv Hetil; 2003 Nov; 144(45):2213-7. PubMed ID: 14686006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
